Healthpeak (DOC) Fundamental Analysis: Revenue, Earnings & Valuation

6.88 / 10

Outperform

Fundamentally, DOC scores 6.9/10 and is rated Outperform. Strengths include Profit‑MV and Cash‑UP, while Net‑income‑Revenue and Revenue‑MV lag. Overall quality is solid, supporting a positive outlook.

Analysis Checks(5/10)

Revenue-MV

Value-0.43

Score0/3

Weight-2.03%

1M Return-0.87%

Net assets per share (growth rate compared to beginning of year %)

Value-10.16

Score1/3

Weight-1.54%

1M Return-0.49%

Total operating revenue (YoY growth rate %)

Value4.52

Score3/3

Weight11.09%

1M Return2.71%

Profit-MV

Value-0.81

Score2/3

Weight20.32%

1M Return4.23%

Net income-Revenue

Value0.33

Score0/3

Weight2.70%

1M Return0.70%

PB-ROE

Value-0.51

Score2/3

Weight13.33%

1M Return3.27%

Shareholders’ equity attributable to parent company (growth rate compared to beginning of year %)

Value-10.73

Score0/3

Weight-4.16%

1M Return-1.32%

Income tax / Total profit (%)

Value3.27

Score1/3

Weight2.53%

1M Return0.75%

Cash-UP

Value-0.17

Score3/3

Weight46.85%

1M Return7.45%

Asset-MV

Value0.59

Score3/3

Weight10.92%

1M Return6.25%

Is DOC undervalued or overvalued?

DOC scores 6.88/10 on fundamentals and holds a Discounted valuation at present. Backed by its 0.81% ROE, 3.58% net margin, 163.58 P/E ratio, 1.39 P/B ratio, and -72.22% earnings growth, these metrics solidify its Outperform investment rating.